-
Characteristics of the included randomized controlled trials.
Characteristics of the included randomized controlled trials. -
r37980778c78--9e5fc617ca287138be756ad64a19814d
Consistency analyses of multiple comparison analyses for the overall composite measure in part A: 0–3 months (top right) and 4–6 months (top left) and part B: 7–9 months (bottom... -
r37980778c78--8e23f09aadc0ab34f494199bb4bd7269
Characteristics of the 78 studies with 34685 patients included in the network Meta-analysis Duration > = 8w. -
r37980778c78--961a4118b52f3da093cbc6e1708f932e
IntroductionAdherence-enhancing interventions have been assessed in the literature, however heterogeneity and conflicting findings have prohibited a consensus on the most... -
r37980778c78--da6ab6c3a869984e5843e2204a766bcc
SUCRA-Based Primary Efficacy and Safety Outcome Rankings from Normotensive RCTs. -
Risk of bias assessment.
Table 2 Assessment of the risk of bias in individual studies based on (1) exposure determination which includes standardization of age and assessment of LUTS severity by IPSS... -
r37980778c78--a290529fcaeb58f551d5c2306f0dba4e
BackgroundInfection in acute pancreatitis (AP) is associated with nutritional therapies including naso-gastric (NG), naso-jejunal (NJ), and total parenteral nutrition (TPN). To... -
r37980778c78--e66485ec446d247b032c901dd51a401d
ObjectiveTo synthesize current evidence of the impact of Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) on hypoglycemia, treatment discontinuation and glycemic level in... -
SUCRA-Based Primary Efficacy and Safety Outcome Rankings from Hypertensive RCTs.
SUCRA-Based Primary Efficacy and Safety Outcome Rankings from Hypertensive RCTs. -
Clinical value of different anti-D immunoglobulin strategies for preventing R...
BackgroundSeveral anti-D immunoglobulin strategies exist for preventing Rh hemolytic disease of the fetus and newborn. This study systematically assessed the clinical value of... -
SUCRA-Based Primary Efficacy and Safety Outcome Rankings from All RCTs.
SUCRA-Based Primary Efficacy and Safety Outcome Rankings from All RCTs.